Skip Navigation

Text From Here.

Outline of retrospective medical research

Use of materials and medical information arising as a result of medical consultations in retrospective medical research

Introduction

This is a notification regarding the use of materials and medical information arising as a result of the consultations of patients attending Wakayama Medical University’s gastroenterological surgery, endocrine surgery and pediatric surgery clinics (examination materials, biopsy tissue, excised specimens, medical information, etc.) in clinical research. The following retrospective clinical studies have been approved by Wakayama Medical University’s Ethics Committee.

The use of materials and medical information arising as a result of medical consultations

Any materials or medical information arising as a result of medical consultations will be harvested and stored as necessary for your treatment. Subsequently, they are an important test material for medical research, even if they become unnecessary for medical practice. Such materials and medical information are used for the purposes of  research into, for example, the onset and advancement of illness, recurrence and its relationship to prognosis, and the effects and side effects of treatment of illness.

Refusal to participate in research

Since we use the materials or medical information arising as a result of medical consultations for analysis, we will not ask you to do anything new in addition to your treatment. If you do not agree to participation, you will not be put at any disadvantage in future consultations etc. If you wish to refuse to participate in this research, please contact your consulting physician.

Protection of privacy

Information that may identify individuals who have cooperated with this research is strictly protected, and will not be released outside of the department. The results of research implemented as a result of your cooperation may, however, be published at conferences or in academic journals, or recorded on databases, in such a way that ensures neither the names of persons cooperating with the study, nor those of their families, are revealed.

Intellectual property rights and costs of participation

It depends on the research project, but in some cases it is possible to imagine that results may yield intellectual property. In such cases, the rights to such property belong either to the individual researcher, or to the University, and will not belong to individual patients. This position is the same as that held by research institutions in various other countries. Furthermore, the research implemented in these projects has almost no conceivable impact on your medical consultation, and will not cost you anything; nor will you be remunerated in any way.

Enquiries

If you do not understand, or are concerned about, anything relating to this research (or your treatment), please ask us at any time. Contact details are as below.

Contact details

  • TEL.073-441-0613
  • FAX.073-446-6566

 

Name of research project: Research into clinical pathological factors and long-term prognosis through analysis of CEACAM 1 isoform balance occurrence in hepatic cellular cancer (Approved 24th March 2010; No. 755)

  • Outline of research: We are engaged in an investigation of the relationship between adhesion molecule CEACAM 1 and the degree of malignancy in hepatic cellular cancer, in order to be able to predict the cancer’s attributes and make a contribution to future hepatic cellular cancer treatment.
  • Focus: Patients diagnosed with hepatic cellular cancer and undergoing liver resection surgery between April 1995 and March 2007

Name of research project: Research into clinical pathological factors and long-term prognosis through analysis of CEACAM 1 isoform balance occurrence in large intestine cancer (Approved 24th March 2010; No. 762)

  • Outline of research: We are engaged in an investigation of the relationship between adhesion molecule CEACAM 1 and the degree of malignancy in large intestine cancer, in order to be able to predict the cancer’s attributes and make a contribution to future large intestine cancer treatment.
  • Focus: Patients diagnosed with large intestine cancer and undergoing surgery between January 2002 and December 2003

Name of research project: Basic clinical research into degree of differentiation and morphogenesis of large intestine cancer as a result of the occurrence of, and changes to CEACAM 1 (Approved 25th May 2010; No. 802)

  • Outline of research: We are engaged in investigating the relationship between the adhesion molecule CEACAM 1 and the differentiation and morphogenesis of large intestine cancer, in order to be able to predict the cancer’s attributes and make a contribution to future large intestine cancer treatment.
  • Focus: Patients diagnosed with large intestine cancer and undergoing surgery between January 2002 and January 2004